Cisatracurium Besylate 71288-0713

Product NDC

71288-0713

Manufacturer: Meitheal Pharmaceuticals Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 31, 2019
Listing Expires: December 31, 2026
Application: ANDA211668

Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cisatracurium Besylate	200 mg/20mL

Drug Class

Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]

Packaging Options(1)

71288-0713-96

10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-95)

View →